Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment - Ionis Pharmaceuticals (NASDAQ:IONS), Biogen (NASDAQ:BIIB)

Biogen Inc (NASDAQ: BIIB) announced new Spinraza (nusinersen) data that were presented at the SMA Research & Clinical Care Meeting 

Related Keywords

,William Blair ,Ionis Pharmaceuticals Inc ,Research Clinical Care Meeting ,Clinical Care Meeting ,